T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.
Clarient, a provider of comprehensive anatomic pathology and molecular testing services, will acquire Applied Genomics in an all-stock merger worth up to $17.6 million.
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.